From the Patrys website they also have other impressive partners.
AstraZeneca
AZ has exclusive rights to develop PAT-SC1
Patrys earns revenues as the product develops
Debiopharm S.A.
Debiopharm has exclusive rights to develop PAT-PA1
Patrys earns revenues as the product develops
http://www.patrys.com/collaborations.php
ado - 3??, page-18
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $73.58K | 18.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 16801257 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7789761 | 11 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |